Laurence Eisenlohr

Laurence Eisenlohr

Auto-generated profile, based on publicly available information

Laurence Eisenlohr

Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Virology
Verified
Journal Article
Closed access
JCJoseph D. Comber
Joseph D. Comber
TRTara M. Robinson
Tara M. Robinson
NSNicholas A. Siciliano
Nicholas A. Siciliano
Adam SnookAdam Snook
Adam Snook
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
Major histocompatibility complex (MHC) class II-presented peptides can be derived from both exogenous (extracellular) and endogenous (biosynthesized) sources of antigen. Although several endogenous antigen-processing pathways have been reported, little is known about their relative contributions to global CD4+T cell responses against complex antigens. Using influenza virus for this purpose, we assessed the role of macroautophagy, a process in which cytosolic proteins are delivered to the lysosome byde novovesicle formation and membrane fusion. Influenza infection triggered productive macroautophagy, and autophagy-dependent presentation was readily observed with model antigens that naturally traffic to the autophagosome. Furthermore, treatments that enhance or inhibit macroautophagy modulated the level of presentation from these model antigens. However, validated enzyme-linked immunospot (ELISpot) assays of influenza-specific CD4+T cells from infected mice using a variety of antigen-presenting cells, including primary dendritic cells, revealed no detectable macroautophagy-dependent component. In contrast, the contribution of proteasome-dependent endogenous antigen processing to the global influenza CD4+response was readily appreciated. The contribution of macroautophagy to the MHC class II-restricted response may vary depending upon the pathogen.

28 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
STSushila A. Toulmin
Sushila A. Toulmin
CBChaitali Bhadiadra
Chaitali Bhadiadra
APAndrew J. Paris
Andrew J. Paris
JLJeffrey H. Lin
Jeffrey H. Lin
JKJeremy Katzen
Jeremy Katzen
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
Type II alveolar cells (AT2s) are critical for basic respiratory homeostasis and tissue repair after lung injury. Prior studies indicate that AT2s also express major histocompatibility complex class II (MHCII) molecules, but how MHCII expression by AT2s is regulated and how it contributes to host defense remain unclear. Here we show that AT2s express high levels of MHCII independent of conventional inflammatory stimuli, and that selective loss of MHCII from AT2s in mice results in modest worsening of respiratory virus disease following influenza and Sendai virus infections. We also find that AT2s exhibit MHCII presentation capacity that is substantially limited compared to professional antigen presenting cells. The combination of constitutive MHCII expression and restrained antigen presentation may position AT2s to contribute to lung adaptive immune responses in a measured fashion, without over-amplifying damaging inflammation.

31 March 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
EGElliot Goodenough
Elliot Goodenough
TRTara M. Robinson
Tara M. Robinson
MZMatthew B. Zook
Matthew B. Zook
KFKevin M. Flanigan
Kevin M. Flanigan
JAJohn Atkins
John Atkins
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
Significance: Many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, are caused by a defective protein resulting from a premature termination codon (PTC) in the mutant gene. Aminoglycosides have been proposed as therapies for these disorders because they increase the frequency of translational read-through of PTCs, permitting expression of full-length protein. We consider the possibility that this approach may prompt an autoimmune response to HLA-presented epitopes encoded downstream of the PTC or other stop codons. We demonstrate that gentamicin induces immunologically relevant levels of an epitope derived from PTC read-through. Furthermore, we identify multiple HLA class I-binding peptides derived from read-through of conventional stop codons in gentamicin-treated cells. These results substantiate the possibility of immune autoreactivity from read-through therapies.

1 May 2007 in Nature Reviews Immunology
Verified
Journal Article
Open access
PDF file
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
LHLan Huang
Lan Huang
TGTania N. Golovina
Tania N. Golovina
The DRiP hypothesis proposes that most peptides that bind to MHC class I molecules are derived from newly synthesized defective proteins. Here, the authors revise this hypothesis and propose that some peptides result from the random delivery of unchaperoned nascent polypeptides to the proteasome. The notion that peptides bound to MHC class I molecules are derived mainly from newly synthesized proteins that are defective, and are therefore targeted for immediate degradation, has gained wide acceptance. This model, still entirely hypothetical, has strong intuitive appeal and is consistent with some experimental results, but it is strained by other findings, as well as by established and emerging concepts in protein quality control. While not discounting defectiveness as a driving force for the processing of some proteins, we propose that MHC-class-I-restricted epitopes are derived mainly from nascent proteins that are accessed by the degradation machinery prior to any assessment of fitness, and we outline one way in which this could be accomplished.

4 March 2011 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
LHLan Huang
Lan Huang
MKMatthew C Kuhls
Matthew C Kuhls
LELaurence C Eisenlohr
Laurence C Eisenlohr
The forces that drive conversion of nascent protein to major histocompatibility complex (MHC) class I‐restricted peptides remain unknown. We explored the fundamental property of overt hydrophobicity as such a driver. Relocation of a membrane glycoprotein to the cytosol via signal sequence ablation resulted in rapid processing of nascent protein not because of the misfolded luminal domain but because of the unembedded transmembrane (TM) domain, which serves as a dose‐dependent degradation motif. Dislocation of the TM domain during the natural process of endoplasmic reticulum‐associated degradation (ERAD) similarly accelerated peptide production, but in the context of markedly prolonged processing that included nonnascent species. These insights into intracellular proteolytic pathways and their selective contributions to MHC class I‐restricted peptide supply, may point to new approaches in rational vaccine design.

12 October 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MHMichael J. Hogan
Michael J. Hogan
NMNikita Maheshwari
Nikita Maheshwari
BBBridget E. Begg
Bridget E. Begg
ANAnnalisa Nicastri
Annalisa Nicastri
EHEmma J. Hedgepeth
Emma J. Hedgepeth
LELaurence C. Eisenlohr
Laurence C. Eisenlohr